All Steripath Micro needle configurations incorporate the BD Vacutainer UltraTouch push-button blood collection set. Credit: PRNewswire / Magnolia Medical Technologies.

Magnolia Medical Technologies has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for 19 new Steripath Micro configurations within its Initial Specimen Diversion Device (ISSD) product family.

Hospitals can use the new options including direct-to-bottle and BD VacutainerUltraTouch push-button blood collection set configurations, to meet the requirements of all patient populations.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Magnolia Medical CEO Greg Bullington said: “We are delighted to launch the expanded family of Steripath Micro configurations as an integral part of our Initial Specimen Diversion Device portfolio.

“We developed the Steripath Micro platform in close collaboration with our customers to ensure the ability to provide improved blood culture accuracy for all patient populations including those that are most vulnerable.”

Steripath Micro is claimed to be the only FDA 510(k)-approved low-diversion volume blood culture collection device family with a specific indication for the reduction of blood culture contamination.

Magnolia Medical developed Steripath Micro in partnership with several hospital-based clinicians. The system optimises the blood culture collection process.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

All needle configurations in Steripath Micro incorporate the BD VacutainerUltraTouch push-button blood collection set.

UltraTouch needles feature an ultra-thin–wall cannula, which extends the inner diameter while maintaining a true–to–gauge size outer diameter.

With the BD PentaPoint cannula technology incorporated, the BD VacutainerUltraTouch is able to easily penetrate the skin for a comfortable patient experience.

In October last year, Becton, Dickinson and Company (BD) signed a co-exclusive commercial agreement with Magnolia Medical to co-sell and co-market the latter’s Steripathand SteripathMicro ISDDplatforms.